^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

BCL2 overexpression

i
Other names: BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
Entrez ID:
BCL2 overexpression
Multiple Myeloma
venetoclax
Sensitive
:
B
BCL2 overexpression
Diffuse Large B Cell Lymphoma
zanubrutinib
Sensitive
:
C3
BCL2 overexpression
Acute Myelogenous Leukemia
7+3 (DAC)
Resistant
:
C3
BCL2 overexpression
Squamous Cell Carcinoma of Head and Neck
cisplatin + 5-fluorouracil
Sensitive
:
C3
BCL2 overexpression
Diffuse Large B Cell Lymphoma
azacitidine oral
Sensitive
:
C3
BCL2 overexpression
Diffuse Large B Cell Lymphoma
R-CHOP
Resistant
:
C3
BCL2 overexpression
Hodgkin Lymphoma
BEACOPP
Resistant
:
C3
BCL2 overexpression
Non Small Cell Lung Cancer
AZD2811
Resistant
:
D
BCL2 overexpression
Hodgkin Lymphoma
venetoclax
Resistant
:
D
BCL2 overexpression
Diffuse Large B Cell Lymphoma
APG-2575
Sensitive
:
D
BCL2 overexpression
Acute Myelogenous Leukemia
IACS-010759
Resistant
:
D
BCL2 overexpression
Multiple Myeloma
bortezomib + A-1331852
Sensitive
:
D
BCL2 overexpression
Acute Myelogenous Leukemia
venetoclax + AZD5991
Sensitive
:
D
BCL2 overexpression
Lung Cancer
osimertinib
Sensitive
:
D
BCL2 overexpression
Lung Cancer
afatinib
Sensitive
:
D
BCL2 overexpression
Lung Cancer
venetoclax + gefitinib
Sensitive
:
D
BCL2 overexpression
Lung Cancer
gefitinib + ABT 263
Sensitive
:
D